Project Description

National Enzyme Company

Prairie Capital Fund V

Location Forsythe, MO
Transaction Type Growth Buyout with Management
Investment Date October 2015
Exit Date July 2018
Buyer Deerland Probiotics & Enzymes
Business

FDA-compliant manufacturer of specialty enzymes and other digestive health products to the vitamins, minerals and supplements industry in the U.S. and globally.

Industry Consumer, Healthcare

Investment Rationale

  • Market leader in an attractive and growing niche
  • Attractive industry dynamics
  • Deep management team
  • Industry where Prairie has significant experience and related expertise
  • Attractive new service lines

Value Add

  • Human Capital
  • Sales & Marketing
  • Infrastructure

My staff and I rate their professionalism, honesty and genuine friendliness second to none. Right from the start, we knew the principals were very interested in the business and the right outcome for both parties. Every conversation involved complete team participation.

A few years later, I can say it’s been an absolute pleasure working with Prairie. They are “noses in, hands off”, just as they promised. They care about the well being of all employees, not just senior staff.

Bottom line: After 47 years in business, the Prairie transaction was the best and most enjoyable acquisition transaction of my career.

Charlie Amidon, Former President and COO